Health
Most baby foods may not meet nutritional guidelines and use 'misleading claims,' study finds
As much as 60% of baby foods on the market may not meet the nutritional standards set by the World Health Organization (WHO), a new study found.
The findings were published in the journal Nutrients last week.
Researchers at The George Institute for Global Health — an independent medical research institute headquartered in Australia — reviewed 651 infant and toddler food products sold in the top 10 U.S. grocery chains, according to a press release.
10 SURPRISING FACTS ABOUT PEANUT ALLERGIES, ACCORDING TO A PEDIATRIC IMMUNOLOGIST
Seventy percent of the products did not include adequate amounts of protein, 25% did not meet calorie requirements, and 20% had sodium levels that exceeded WHO’s recommendations.
The researchers compared the foods’ data to WHO’s nutrient and promotion profile model (NPPM), which supports “appropriate promotion of food products” for infants and young children in Europe.
As much as 60% of baby foods on the market may not meet the nutritional standards set by the World Health Organization, a new study has found. (iStock)
Baby food “pouches” were ranked as some of the least healthy choices, with fewer than 7% meeting total sugar recommendations, the institute noted.
BACK-TO-SCHOOL LUNCH IDEAS FOR KIDS HAVE A HEALTHY, INTERACTIVE TWIST
Infant formulas were not included in the study, as those are regulated separately by the U.S. Food and Drug Administration (FDA), the researchers noted.
“Only products available in the baby food section of the grocery store were included. This meant [that] yogurts located in the fridge section, drinks section, or under the ‘dairy, eggs and fridge’ tab online were not included,” they wrote.
Convenience foods labeled as culprits
Dr. Elizabeth Dunford, research fellow at The George Institute and adjunct assistant professor of nutrition at the University of North Carolina, expressed concern about the prevalence of “processed convenience foods” for babies and toddlers.
Baby food pouches were ranked the unhealthiest of the reviewed options. (iStock)
“Early childhood is a crucial period of rapid growth, and when taste preferences and dietary habits form, potentially paving the way for the development of chronic diseases such as obesity, diabetes and some cancers later in life,” Dunford said in the release.
“Time-poor parents are increasingly choosing convenience foods, unaware that many of these products lack key nutrients needed for their child’s development and tricked into believing they are healthier than they really are.”
A ‘health halo’
The study also highlighted “misleading marketing practices,” claiming that more than 99% of baby food products contained at least one “prohibited claim” on the packaging.
“We found that all but four products featured at least one prohibited claim on the pack, with an average of four prohibited claims per pack,” Dr. Daisy Coyle, research fellow and dietitian at The George Institute, told Fox News Digital.
TODDLER MILK IS ‘POTENTIALLY HARMFUL,’ AAP WARNS AMID CALLS FOR STRICTER REGULATIONS
“These claims often give products a ‘health halo,’ deceiving busy parents into thinking they are a lot healthier than they are.”
Some of the most-cited misleading verbiage included “non-genetically modified (GM),” “organic,” “no BPA” and “no artificial colors/flavors.”
“These numbers are truly alarming when you consider we’re talking about food for infants and toddlers,” a nutritionist told Fox News Digital. (iStock)
“We saw this not only in the use of misleading claims, but also in the use of misleading names, where the product name did not reflect the main ingredients found on the ingredient list.”
Some products claimed to be “fruits” or “vegetables” even though those were not the primary ingredients, for example.
Among U.S. children 2 to 5 years old, the prevalence of obesity was 12.7% from 2017 to March 2020.
“Our findings highlight the urgent need for better regulation and guidance in the infant and toddler foods market in the United States — the health of future generations depends on it,” added Dunford.
Among U.S. children 2 to 5 years old, the prevalence of obesity was 12.7% from 2017 to March 2020, according to data from the Centers for Disease Control and Prevention (CDC).
Based on the study findings, the researchers advised parents and caregivers to pay close attention to the claims made on baby food packaging. (iStock)
Based on the study findings, the researchers advised parents and caregivers to pay close attention to the claims made on baby food packaging.
“The ingredients list and nutrition label provide a far more accurate representation of what is in the product,” Coyle said. “One important thing to look out for is the amount of added sugar.”
Fox News Digital reached out to the American Academy of Pediatrics, major baby food manufacturers and WHO requesting comment.
‘Critical issue’
Katie Thomson, an Oregon-based registered dietitian and founder of the Square Baby nutrition system, was not involved in the study but said it sheds light on a “critical issue.”
“These numbers are truly alarming when you consider we’re talking about food for infants and toddlers,” she told Fox News Digital.
“Time-poor parents are increasingly choosing convenience foods, unaware that many of these products lack key nutrients needed for their child’s development,” a nutritionist warned. (iStock)
“The core issue is that many of these products, especially pouches, are far too sweet to offer proper, balanced nutrition. This not only fails to meet nutritional needs, but also hinders the development of a child’s palate.”
“We’re essentially setting them up for a lifetime of poor eating habits.”
CHILDHOOD MEDICAL MYTHS DEBUNKED AS EXPERTS WEIGH IN ON 5 COMMON WARNINGS
As a mother, Thomson said, she understands the appeal of convenient, self-feeding options like pouches — but warned that this approach is “ultimately detrimental to children’s long-term health and eating habits.”
Lack of protein is the most glaring issue, according to Thomson — “it’s fundamental for everything from muscle development to immune function in growing bodies.”
“Many of these foods are also lacking in healthy fats, which are essential for brain development, and important micronutrients like calcium, iron and vitamin D,” she said.
“There’s also a noticeable absence of those nutrient-dense green and earthy vegetables.”
The researchers reviewed 651 infant and toddler food products sold in the top 10 U.S. grocery chains. (iStock)
Another often overlooked aspect, Thomson noted, is failure to include common allergens.
“Early introduction of allergens, like peanuts, eggs and dairy, can actually help prevent food allergies from developing,” she said.
CLICK HERE TO SIGN UP FOR OUR HEALTH NEWSLETTER
“However, many baby food products fail to include these important components, which can create a whole host of health issues later in life.”
When choosing nutrition for babies, Thomson recommends offering a diverse range of foods, flavors, textures and colors, with a balance of fat, fiber and protein, while keeping sugar content low.
Infant formulas were not included in the study, as those are regulated separately by the U.S. Food and Drug Administration, the researchers noted. (iStock)
She recommends the following breakdown for a 4-ounce balanced meal.
- Less than 6 grams of sugar
- 2-4 grams of fat
- 2-4 grams of fiber
- 2-5 grams of protein
Potential limitations
The George Institute for Global Health, which has received previous funding from the Bill & Melinda Gates Foundation, the National Health and Medical Research Council, and other investors, stated that it received no external funding for this specific study.
The study did have some limitations, the researchers acknowledged.
“Although we analyzed data from a large representative dataset, we were unable to link to sales data for each product,” Coyle told Fox News Digital.
“More research is needed to know whether American families are more likely to purchase products that fail to meet WHO requirements,” the researchers said. (iStock)
“More research is needed to know whether American families are more likely to purchase products that fail to meet WHO requirements.”
Another limitation was that the WHO NPPM was developed for the European region.
So it is “not necessarily 100% applicable to the U.S. infant and toddler foods market,” the researchers stated in the findings.
For more Health articles, visit www.foxnews/health
Parents and carers are not to blame, the researchers emphasized.
Coyle of The George Institute told Fox News Digital that “government regulation” is needed “to transform this sector to ensure infant and toddler foods are healthy and marketed appropriately.”
She added, “The health of our youngest generation and future generations depends on it.”
Health
Hidden factor in cancer treatment timing may affect survival, researchers say
NEWYou can now listen to Fox News articles!
The time of day patients receive cancer treatments could have an impact on the outcome, a new study suggests.
New research published in Cancer, the official journal of the American Cancer Society, found that patients who received standard immunochemotherapy for extensive-stage small cell lung cancer (ES-SCLC) earlier in the day saw “significantly greater benefit” compared to those who got the same treatment later in the afternoon.
In the study, researchers from the Affiliated Cancer Hospital of Xiangya School of Medicine at Central South University, China, analyzed data from nearly 400 patients who were treated between May 2019 and October 2023.
FAST-GROWING CANCER COULD BE SLOWED BY COMMON BLOOD PRESSURE DRUG, RESEARCH SHOWS
All patients had ES-SCLC and received first-line immunotherapy (atezolizumab or durvalumab) along with chemotherapy, according to a press release.
“Our study found that patients who received immunochemotherapy before 3:00 PM had substantially longer progression-free survival and overall survival,” lead study author Dr. Yongchang Zhang, medical oncologist and chief director at the Hunan Cancer Hospital in Changsha, China, told Fox News Digital.
The time of day patients receive cancer treatments could have an impact on the outcome, a new study suggests. (iStock)
“After adjusting for multiple confounding factors, earlier administration was associated with a 52% lower risk of cancer progression and a 63% lower risk of death.”
“It was quite surprising that simply changing the infusion time could lead to such substantial survival benefits for patients,” he added.
TWO POPULAR TYPES OF EXERCISE COULD REDUCE CANCER GROWTH, STUDY FINDS
The findings align with the idea of chronotherapy, which suggests that the body’s natural daily rhythms affect how the immune system works and how drugs act in the body.
This means cancer treatments may be more effective at certain times of day, likely because immune activity and drug processing change over the 24-hour cycle, the study suggests.
“This study should not prompt patients to delay treatment or panic about appointment times.”
Based on the findings, Zhang recommends scheduling immunotherapy infusions in the early part of the day.
“Research across multiple cancer types has shown that patients receiving immunotherapy earlier in the day experience longer survival,” he noted. “Our findings in non-small cell lung cancer, supported by both multicenter retrospective studies and prospective clinical trials, confirm this pattern.”
NEW CANCER THERAPY HUNTS AND DESTROYS DEADLY TUMORS IN MAJOR BREAKTHROUGH STUDY
Gilberto Lopes, M.D., chief of medical oncology at the Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine, noted that previous, similar studies in non-small cell lung cancer have shown better outcomes when immunotherapy is administered earlier in the day, reinforcing the idea that the immune system follows circadian rhythms that influence treatment response.
CLICK HERE TO SIGN UP FOR OUR HEALTH NEWSLETTER
“In that sense, the results are biologically plausible and consistent with a growing body of evidence across cancers,” Lopes, who was not involved in the study, told Fox News Digital. “What is striking is that this signal now appears in small cell lung cancer, a disease where outcomes have been notoriously difficult to improve.”
All patients had ES-SCLC and received first-line immunotherapy (atezolizumab or durvalumab) along with chemotherapy. (iStock)
The study did have some limitations, as detailed in the published study. Most notably, the study was retrospective and observational, meaning it could not prove a cause-and-effect relationship between timing of treatments and outcomes.
CLICK HERE TO DOWNLOAD THE FOX NEWS APP
With this type of study, Lopes said, “investigators start with an idea and go back and review patient records.” In this case, other factors can have an impact on the outcome, according to the oncologist.
TEST YOURSELF WITH OUR LATEST LIFESTYLE QUIZ
“For instance, did patients who come early in the day have a better quality of life, performance status and socioeconomic status and that is what made the difference?” he asked. “Or something else we don’t know? These results need to be confirmed prospectively to eliminate known and unknown sources of bias.”
“The next step is prospective testing, but until then, this research invites us to rethink something medicine usually ignores: timing itself,” an oncologist said. (iStock)
Zhang also pointed out that this was a single-center study including only Chinese patients. “To obtain more definitive evidence, prospective clinical trials conducted across multiple countries and diverse populations are needed,” he told Fox News Digital.
Looking ahead, the researchers plan to conduct randomized trials to confirm these preliminary findings and pinpoint optimal treatment windows based on individual patients’ chronotypes (internal body clocks).
CLICK HERE FOR MORE HEALTH STORIES
“This study should not prompt patients to delay treatment or panic about appointment times,” Lopes cautioned. “But it raises an important, low-cost question for oncology systems: If scheduling flexibility exists, should earlier infusion times be preferred?”
“The next step is prospective testing, but until then, this research invites us to rethink something medicine usually ignores: timing itself.”
Health
Widely prescribed opioid shows minimal pain relief and higher heart risk, study finds
NEWYou can now listen to Fox News articles!
A widely prescribed opioid painkiller showed limited effectiveness and increased risk of negative effects in a new analysis published in BMJ Evidence-Based Medicine.
The study examined tramadol, a common prescription opioid used to treat chronic pain.
Tramadol has historically been perceived as a safer or less addictive opioid, which has contributed to its widespread use in chronic pain treatment, the study authors noted.
PSYCHIATRIST REVEALS HOW SIMPLE MINDSET SHIFTS CAN SIGNIFICANTLY REDUCE CHRONIC PAIN
“Often, we may use tramadol to avoid more addictive drugs like other opioids, though in fact tramadol is a synthetic opioid. It is much milder,” Dr. Marc Siegel, senior medical analyst for Fox News, told Fox News Digital.
In the new analysis, researchers used data from 19 randomized clinical trials involving 6,506 adults with conditions including osteoarthritis, chronic low back pain, neuropathic pain and fibromyalgia. All the studies compared tramadol to a placebo treatment.
The level of pain relief associated with tramadol fell below the threshold typically considered clinically important. (iStock)
Overall, tramadol led to a small decrease in pain, but the amount of relief was less than what is usually considered clinically meaningful, the authors reported.
“It is notable how minimal the pain reduction was and how clearly the study highlighted the elevated risk of serious adverse events, even over relatively short trial durations,” Alopi M. Patel, M.D., pain medicine physician at Icahn School of Medicine at Mt. Sinai in New York City, told Fox News Digital. (Patel was not involved in the study.)
MORE PEOPLE TURN TO ACUPUNCTURE FOR BACK PAIN AS STUDY SHOWS RELIEF
Participants receiving tramadol experienced a higher risk of adverse events, both serious and non-serious, compared with those receiving a placebo.
Serious adverse events primarily included cardiovascular events, such as chest pain, coronary artery disease and congestive heart failure. The authors concluded that tramadol likely increases the risk of heart-related issues.
Serious adverse events were primarily driven by cardiovascular outcomes, including chest pain, coronary artery disease and congestive heart failure. (iStock)
The authors concluded that the benefits of tramadol for chronic pain are small and that the harms likely outweigh the benefits. The findings call into question the use of tramadol for chronic pain conditions, they stated.
Study limitations
Most of the trials included in the analysis were short, with treatment periods ranging from two to 16 weeks and follow-up periods from three to 15 weeks.
CLICK HERE TO SIGN UP FOR OUR HEALTH NEWSLETTER
This limited the ability to assess long-term outcomes, the researchers acknowledged.
The authors reported that many outcomes had a high risk of bias, which may have exaggerated the apparent benefits and minimized the reported harms.
CLICK HERE TO DOWNLOAD THE FOX NEWS APP
The trials involved several different types of chronic pain, but the data were not detailed enough to draw conclusions for any specific condition. This makes it “harder to generalize the findings to specific patient populations,” noted Patel.
Most trials were short in duration and compared tramadol only with a placebo — limiting conclusions about long-term effects and comparisons with other treatments. (iStock)
Though the study has value, Siegel said, “looking at slight increased rates of cancer or heart disease among those on the drug is completely misleading, because it is not controlled for other factors and there is no evidence or hint of causation.”
“You would have to first look at underlying characteristics of that group who took the meds.”
CLICK HERE FOR MORE HEALTH STORIES
The doctor also pointed out that the study “doesn’t compare [tramadol] with full-on opioids like Percocet.”
Experts emphasize that patients should not stop taking tramadol abruptly, as doing so can lead to withdrawal symptoms. Those looking to change their medication should consult a doctor.
TEST YOURSELF WITH OUR LATEST LIFESTYLE QUIZ
“I recommend that clinicians and patients engage in transparent, shared decision-making that considers tramadol’s modest benefits alongside its risks,” Patel advised.
Fox News Digital reached out to several manufacturers of tramadol requesting comment.
Health
Flu by state: Where this season’s highly contagious variant is spreading the most
New flu strain emerging as a severe health threat
Fox News senior medical analyst Dr. Marc Siegel joins ‘America’s Newsroom’ to warn of a new strain of the flu that is spiking hospitalizations across the country and newfound risks of medical marijuana’s link to psychosis.
NEWYou can now listen to Fox News articles!
A new form of the flu, which is highly contagious and aggressive, is sweeping the nation this season.
A mutation of influenza A H3N2, called subclade K, has been detected as the culprit in rising global cases, including in the U.S.
The World Health Organization stated on its website that the K variant marks “a notable evolution in influenza A (H3N2) viruses,” which some say calls into question the effectiveness of this season’s influenza vaccine against the strain.
‘AGGRESSIVE’ NEW FLU VARIANT SWEEPS GLOBE AS DOCTORS WARN OF SEVERE SYMPTOMS
The K variant causes more intense flu symptoms, including fever, chills, headache, fatigue, cough, sore throat and runny nose, according to experts.
Multiple states in the northeast are reporting high rates of respiratory illness this month. (iStock)
Among 216 influenza A(H3N2) viruses collected since Sept. 28, 89.8% belonged to subclade K, a CDC report states.
The agency continues to release a weekly influenza surveillance report, tracking which states are seeing the most activity for outpatient respiratory illness.
5 THINGS YOU NEED TO KNOW BEFORE GETTING YOUR FLU SHOT, ACCORDING TO DOCTORS
Below are the states and regions within the highest range of reported medical visits, not necessarily confirmed influenza cases, as of the week ending Dec. 13.
The CDC’s weekly influenza surveillance report, an outpatient respiratory illness activity map, based on data reported to ILINet for the week ending Dec. 13, 2025. (CDC FluView)
Very High (Level 1)
Very High (Level 2)
Very High (Level 3)
- New Jersey
- Rhode Island
- Louisiana
- Colorado
CLICK HERE TO SIGN UP FOR OUR HEALTH NEWSLETTER
High (Level 1)
- Massachusetts
- Connecticut
- Michigan
- Idaho
- South Carolina
High (Level 2)
CLICK HERE TO DOWNLOAD THE FOX NEWS APP
High (Level 3)
- Washington, D.C.
- Maryland
- North Carolina
- Georgia
The CDC has estimated that there have been at least 4.6 million illnesses, 49,000 hospitalizations and 1,900 flu deaths this season so far. The flu vaccine is recommended as the best line of defense against the virus.
The flu vaccine is recommended as the best line of defense against the virus. (iStock)
In an interview with Fox News Digital, Dr. Neil Maniar, professor of public health practice at Boston’s Northeastern University, shared details on the early severity of this emerging flu strain.
“It’s becoming evident that this is a pretty severe variant of the flu,” he said. “Certainly, in other parts of the world where this variant has been prevalent, it’s caused some severe illness, and we’re seeing an aggressive flu season already.”
TEST YOURSELF WITH OUR LATEST LIFESTYLE QUIZ
Subclade K is the “perfect storm” for an aggressive flu season, Maniar suggested, as vaccination rates overall are down, and it’s uncertain whether this year’s flu vaccine directly addresses this specific mutation.
“The vaccine is very important to get, but because it’s not perfectly aligned with this variant, I think that’s also contributing to some degree to the severity of cases we’re seeing,” he said. “We’re going in [to this flu season] with lower vaccination rates and a variant that in itself seems to be more aggressive.”
Subclade K has “caused some severe illness, and we’re seeing an aggressive flu season already,” a doctor said. (iStock)
Maniar stressed that it’s not too late to get the flu vaccine, as peak flu season has not yet arrived.
“The vaccine still provides protection against serious illness resulting from the subclade K variant that seems to be going around,” he said. “There are likely to be lots of indoor gatherings and other events that create risk of exposure, so protection is important.”
CLICK HERE FOR MORE HEALTH STORIES
Even healthy individuals can become seriously ill from the flu, Maniar noted, “so a vaccine is beneficial for almost everyone.”
“Individuals typically start to develop some degree of protection within a few days and gain the full benefit within about two weeks, so now is the time for anyone who hasn’t gotten the vaccine yet.”
-
Maine1 week agoElementary-aged student killed in school bus crash in southern Maine
-
Massachusetts1 week agoMIT professor Nuno F.G. Loureiro, a 47-year-old physicist and fusion scientist, shot and killed in his home in Brookline, Mass. | Fortune
-
New Mexico1 week agoFamily clarifies why they believe missing New Mexico man is dead
-
Culture1 week agoTry This Quiz and See How Much You Know About Jane Austen
-
World6 days agoPutin says Russia won’t launch new attacks on other countries ‘if you treat us with respect’
-
Minneapolis, MN1 week agoMinneapolis man is third convicted in Coon Rapids triple murder
-
Maine1 week agoFamily in Maine host food pantry for deer | Hand Off
-
Culture1 week agoRevisiting Jane Austen’s Cultural Impact for Her 250th Birthday